Rimegepant
- Product Name
- Rimegepant
- CAS No.
- 1289023-67-1
- Chemical Name
- Rimegepant
- Synonyms
- BMS-927711;BMS 927711;CS-2806;BHV-3000;BMS 92771;Rimegepan;Remazepam;Rimegepant;BMS927711;BMS 927711;BMS-927711(Rimegepant)
- CBNumber
- CB42645135
- Molecular Formula
- C28H28F2N6O3
- Formula Weight
- 534.56
- MOL File
- 1289023-67-1.mol
Rimegepant Property
- Density
- 1.45±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- A crystalline solid
- pka
- 12.03±0.20(Predicted)
N-Bromosuccinimide Price
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 1mg
- Price
- $43
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 5mg
- Price
- $189
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 10mg
- Price
- $334
- Updated
- 2023/06/20
- Product number
- 26338
- Product name
- Rimegepant
- Packaging
- 25mg
- Price
- $678
- Updated
- 2023/06/20
- Product number
- R517100
- Product name
- Rimegepant
- Packaging
- 500mg
- Price
- $15225
- Updated
- 2021/12/16
Rimegepant Chemical Properties,Usage,Production
Description
Rimegepant (Nurtec ODT)(FDA approved in February 2020) is an ODT available in a single strength of 75 mg for the acute treatment of migraine with or without aura in adults.No more than 75 mg should be taken in a 24-hour period. while there are no contraindications，concomitant administration with CYP3A4 inhibitors should be avoided.The most common adverse reaction is nausea, occurring in few patients (rimegepant PI, 2020). In clinical trials, a single 75-mg dose of rimegepant demonstrated superiority over placebo with regard to freedom from pain (21% in the rimegepant group vs.11% in the placebo group) and freedom from the most bothersome symptom (35% vs. 27%) at 2 hours post dose (Croop et al., 2019). Rimegepant is not approved for migraine prevention, although it is presently in late-stage clinical trials assessing it for that indication(NCT03732638,2020).
Uses
Rimegepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist used for the treatment of migraine.
Rimegepant Preparation Products And Raw materials
Raw materials
Preparation Products
Rimegepant Suppliers
- Tel
- 13327700685
- Fax
- +86-25-58744115
- sales@vcarepharmatech.com
- Country
- China
- ProdList
- 310
- Advantage
- 61
- Tel
- 14793566
- info@cenpharm.com
- Country
- China
- ProdList
- 698
- Advantage
- 58
- Tel
- 0576-89085261 15867635987
- Fax
- 0576-89085262
- jasonhu09@163.com
- Country
- China
- ProdList
- 442
- Advantage
- 50
- Tel
- 0755-61160828 15994832653
- Fax
- 0755-61160828
- hulixiu@yunfeipharma.com
- Country
- China
- ProdList
- 248
- Advantage
- 58
- Tel
- -1345456643 15315114555
- Fax
- QQ:1345456643
- 1345456643@qq.com
- Country
- China
- ProdList
- 223
- Advantage
- 58
- Tel
- 0531-69954981 88963280 18396830603
- Fax
- 0531-88964879
- sales@boyuanpharm.com
- Country
- China
- ProdList
- 230
- Advantage
- 58
- Tel
- 18632776803
- 355803330@qq.com
- Country
- China
- ProdList
- 554
- Advantage
- 58
- Tel
- 0551-68779238 18056025720
- sales3@lcywhx.com
- Country
- China
- ProdList
- 159
- Advantage
- 57
- Tel
- 021-50460086-9 15921403865
- Fax
- +86-21-50462321
- han_yajun@dctc.daicel.com
- Country
- China
- ProdList
- 7191
- Advantage
- 65
- Tel
- 021-58950125
- Fax
- (86) 21-58955996
- info@chemexpress.com
- Country
- China
- ProdList
- 7552
- Advantage
- 61
View Lastest Price from Rimegepant manufacturers
- Product
- Rimegepant 1289023-67-1
- Price
- US $0.00-0.00/g
- Min. Order
- 10g
- Purity
- 99%
- Supply Ability
- 5kgs
- Release date
- 2024-11-05
- Product
- BMS-927711 1289023-67-1
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- 98% HPLC
- Supply Ability
- 100kg
- Release date
- 2023-08-14
- Product
- Rimegepant 1289023-67-1
- Price
- US $20.00/KG
- Min. Order
- 1KG
- Purity
- 0.99
- Supply Ability
- 20
- Release date
- 2023-09-05